Your browser doesn't support javascript.
loading
Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients.
Fragkou, Paraskevi C; Palaiodimou, Lina; Stefanou, Maria Ioanna; Katsanos, Aristeidis H; Lambadiari, Vaia; Paraskevis, Dimitrios; Andreadou, Elisabeth; Dimopoulou, Dimitra; Zompola, Christina; Ferentinos, Panagiotis; Vassilakopoulos, Theodoros I; Kotanidou, Anastasia; Sfikakis, Petros P; Tsiodras, Sotirios; Tsivgoulis, Georgios.
Afiliação
  • Fragkou PC; First Department of Critical Care Medicine and Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece.
  • Palaiodimou L; Second Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Athens, Greece.
  • Stefanou MI; Second Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Athens, Greece.
  • Katsanos AH; Division of Neurology, Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
  • Lambadiari V; Second Department of Internal Medicine Research Unit and Diabetes Center, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Athens, Greece.
  • Paraskevis D; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Andreadou E; First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece.
  • Dimopoulou D; Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, 'Panagiotis and Aglaia Kyriakou' Children's Hospital, Athens, Greece.
  • Zompola C; Second Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Athens, Greece.
  • Ferentinos P; Second Department of Psychiatry, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Athens, Greece.
  • Vassilakopoulos TI; Third Department of Critical Care Medicine, School of Medicine, National and Kapodistrian University of Athens, Evgenideio Hospital, Athens, Greece.
  • Kotanidou A; First Department of Critical Care Medicine and Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece.
  • Sfikakis PP; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsiodras S; Fourth Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Athens, Greece.
  • Tsivgoulis G; Second Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, 'Attikon' University Hospital, Rimini 1, Chaidari, Athens 12462, Greece.
Ther Adv Neurol Disord ; 15: 17562864221099472, 2022.
Article em En | MEDLINE | ID: mdl-35646159

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Ther Adv Neurol Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Ther Adv Neurol Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia